CREBBP and neoplasm: CBP/p300 bind specifically to HIF-1α and are critical co-activators for HIF-1α-mediated gene expression under hypoxia conditions, which underlies tumor angiogenesis, invasion, metastasis, and resistance to therapy [275,276,277].